Xiaofei Mo

591 total citations
22 papers, 408 citations indexed

About

Xiaofei Mo is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaofei Mo has authored 22 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaofei Mo's work include Radiomics and Machine Learning in Medical Imaging (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Vitamin D Research Studies (2 papers). Xiaofei Mo is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Vitamin D Research Studies (2 papers). Xiaofei Mo collaborates with scholars based in China, United States and Norway. Xiaofei Mo's co-authors include Cynthia M. Bulik, Kimberly A. Brownley, Wendy Foulds Mathes, Qidong You, Xiaoli Xu, Jinlian Wei, Yingrui Yang, Xiaojin Zhang, Yuetao Wang and Yuebin Liang and has published in prestigious journals such as Medicine, European Journal of Medicinal Chemistry and BioMed Research International.

In The Last Decade

Xiaofei Mo

21 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaofei Mo China 12 92 81 54 51 49 22 408
Zhipeng Li China 16 28 0.3× 159 2.0× 35 0.6× 23 0.5× 101 2.1× 65 687
Fahimeh Hosseini Iran 7 53 0.6× 90 1.1× 68 1.3× 36 0.7× 95 1.9× 17 531
Marzieh Araghi Sweden 11 24 0.3× 153 1.9× 25 0.5× 73 1.4× 266 5.4× 17 792
Christopher Kaiser United States 18 51 0.6× 89 1.1× 34 0.6× 10 0.2× 157 3.2× 35 856
Matthew Lee United States 9 12 0.1× 116 1.4× 49 0.9× 18 0.4× 34 0.7× 18 344
William Ricketts United Kingdom 12 53 0.6× 258 3.2× 34 0.6× 46 0.9× 88 1.8× 36 630
Chunyan Guo China 15 48 0.5× 200 2.5× 19 0.4× 16 0.3× 36 0.7× 59 615
Peter Thompson United Kingdom 12 36 0.4× 310 3.8× 30 0.6× 27 0.5× 35 0.7× 34 785
Zhibo Zhang China 11 74 0.8× 183 2.3× 55 1.0× 11 0.2× 15 0.3× 46 501

Countries citing papers authored by Xiaofei Mo

Since Specialization
Citations

This map shows the geographic impact of Xiaofei Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofei Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofei Mo more than expected).

Fields of papers citing papers by Xiaofei Mo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofei Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofei Mo. The network helps show where Xiaofei Mo may publish in the future.

Co-authorship network of co-authors of Xiaofei Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofei Mo. A scholar is included among the top collaborators of Xiaofei Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofei Mo. Xiaofei Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mo, Xiaofei, et al.. (2024). Association of serum 25-hydroxy-vitamin D concentration and risk of mortality in cancer survivors in the United States. BMC Cancer. 24(1). 545–545. 4 indexed citations
3.
He, Chen, Jing Chen, Xiaofei Mo, et al.. (2023). Gold Nanoparticles Enhance the Ability of Radiotherapy to Induce Immunogenic Cell Death in Glioblastoma. International Journal of Nanomedicine. Volume 18. 5701–5712. 15 indexed citations
5.
Li, Shiyong, et al.. (2022). A Near-field Millimeter Wave Imaging Approach for Cross MIMO Array. 1–3. 1 indexed citations
6.
Chen, Sijie, Wenjing Zhou, Jian Li, et al.. (2021). A Novel XGBoost Method to Infer the Primary Lesion of 20 Solid Tumor Types From Gene Expression Data. Frontiers in Genetics. 12. 632761–632761. 12 indexed citations
7.
Wang, Wei, et al.. (2021). Efficacy of Anlotinib for the Treatment of Angiosarcoma of the Face and Neck: A Case Report. Frontiers in Oncology. 11. 596732–596732. 7 indexed citations
8.
Li, Tianbao, Tao Huang, Cheng Guo, et al.. (2021). Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review. The Innovation. 2(2). 100116–100116. 46 indexed citations
9.
Mo, Xiaofei, et al.. (2021). Competing risk analysis of cardiovascular/cerebrovascular death in T1/2 kidney cancer: a SEER database analysis. BMC Cancer. 21(1). 13–13. 9 indexed citations
10.
Yang, Jialiang, et al.. (2021). Identification and Validation of Efficacy of Immunological Therapy for Lung Cancer From Histopathological Images Based on Deep Learning. Frontiers in Genetics. 12. 642981–642981. 14 indexed citations
11.
Liang, Xin, Wen Zhu, Bo Liao, et al.. (2020). A Machine Learning Approach for Tracing Tumor Original Sites With Gene Expression Profiles. Frontiers in Bioengineering and Biotechnology. 8. 607126–607126. 4 indexed citations
12.
Wu, Zhijun, Churong Li, Yongcong Cai, et al.. (2020). DeepLRHE: A Deep Convolutional Neural Network Framework to Evaluate the Risk of Lung Cancer Recurrence and Metastasis From Histopathology Images. Frontiers in Genetics. 11. 768–768. 42 indexed citations
13.
He, Binsheng, Junlin Xu, Bo Liao, et al.. (2020). Gene Coexpression Network and Module Analysis across 52 Human Tissues. BioMed Research International. 2020(1). 6782046–6782046. 8 indexed citations
14.
Xu, Xiaoli, Yingrui Yang, Xiaofei Mo, et al.. (2017). Design, synthesis, and evaluation of benzofuran derivatives as novel anti-pancreatic carcinoma agents via interfering the hypoxia environment by targeting HIF-1α pathway. European Journal of Medicinal Chemistry. 137. 45–62. 42 indexed citations
15.
Jiang, Fen, Jiacheng Xu, Huijie Wang, et al.. (2017). Identification and optimization of novel 6-acylamino-2-aminoquinolines as potent Hsp90 C-terminal inhibitors. European Journal of Medicinal Chemistry. 141. 1–14. 15 indexed citations
16.
Wei, Jinlian, Yingrui Yang, Yali Li, et al.. (2016). Synthesis and evaluation of N-(benzofuran-5-yl)aromaticsulfonamide derivatives as novel HIF-1 inhibitors that possess anti-angiogenic potential. Bioorganic & Medicinal Chemistry. 25(6). 1737–1746. 16 indexed citations
17.
Yang, Yingrui, Jinlian Wei, Xiaofei Mo, et al.. (2016). Discovery and optimization of new benzofuran derivatives against p53-independent malignant cancer cells through inhibition of HIF-1 pathway. Bioorganic & Medicinal Chemistry Letters. 26(11). 2713–2718. 14 indexed citations
18.
Mathes, Wendy Foulds, Kimberly A. Brownley, Xiaofei Mo, & Cynthia M. Bulik. (2009). The biology of binge eating. Appetite. 52(3). 545–553. 110 indexed citations
19.
Bulik, Cynthia M., Ann Von Holle, Kelly A. Gendall, et al.. (2008). Maternal eating disorders influence sex ratio at birth. Acta Obstetricia Et Gynecologica Scandinavica. 87(9). 979–981. 20 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026